The global Intermediate Bulk Container (IBC) for Pharmaceutical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intermediate Bulk Container (IBC) for Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intermediate Bulk Container (IBC) for Pharmaceutical.
Report Scope
The Intermediate Bulk Container (IBC) for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intermediate Bulk Container (IBC) for Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intermediate Bulk Container (IBC) for Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Matcon
KIT Co,ltd
THIELMANN
GEA
Dec Group
SCHÄFER Werke GmbH
Premier Tech Ltd.
Ingredient Batching Systems Ltd
ISL Asia Technologies Pte. Ltd.
Segment by Type
Stainless Steel IBC
Polyethylene IBC
Segment by Application
Tablet & Capsules
Powders
Ointments
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intermediate Bulk Container (IBC) for Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intermediate Bulk Container (IBC) for Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Intermediate Bulk Container (IBC) for Pharmaceutical Market Overview
1.1 Product Overview and Scope of Intermediate Bulk Container (IBC) for Pharmaceutical
1.2 Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Type
1.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Value Comparison by Type (2024-2030)
1.2.2 Stainless Steel IBC
1.2.3 Polyethylene IBC
1.3 Intermediate Bulk Container (IBC) for Pharmaceutical Segment by Application
1.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Value by Application: (2024-2030)
1.3.2 Tablet & Capsules
1.3.3 Powders
1.3.4 Ointments
1.3.5 Others
1.4 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue 2019-2030
1.4.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales 2019-2030
1.4.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intermediate Bulk Container (IBC) for Pharmaceutical Market Competition by Manufacturers
2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Average Price by Manufacturers (2019-2024)
2.4 Global Intermediate Bulk Container (IBC) for Pharmaceutical Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intermediate Bulk Container (IBC) for Pharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intermediate Bulk Container (IBC) for Pharmaceutical, Product Type & Application
2.7 Intermediate Bulk Container (IBC) for Pharmaceutical Market Competitive Situation and Trends
2.7.1 Intermediate Bulk Container (IBC) for Pharmaceutical Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intermediate Bulk Container (IBC) for Pharmaceutical Players Market Share by Revenue
2.7.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intermediate Bulk Container (IBC) for Pharmaceutical Retrospective Market Scenario by Region
3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region: 2019-2030
3.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region: 2019-2024
3.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Region: 2025-2030
3.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region: 2019-2030
3.3.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region: 2019-2024
3.3.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Region: 2025-2030
3.4 North America Intermediate Bulk Container (IBC) for Pharmaceutical Market Facts & Figures by Country
3.4.1 North America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2019-2030)
3.4.3 North America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Market Facts & Figures by Country
3.5.1 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2019-2030)
3.5.3 Europe Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Market Facts & Figures by Country
3.6.1 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2019-2030)
3.6.3 Asia Pacific Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2019-2030)
3.7.3 Latin America Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2019-2030)
4.1.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2019-2024)
4.1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Type (2025-2030)
4.1.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Type (2019-2030)
4.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2019-2030)
4.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2019-2024)
4.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Type (2025-2030)
4.2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Type (2019-2030)
4.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2019-2030)
5.1.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2019-2024)
5.1.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales by Application (2025-2030)
5.1.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Sales Market Share by Application (2019-2030)
5.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2019-2030)
5.2.1 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2019-2024)
5.2.2 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue by Application (2025-2030)
5.2.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Revenue Market Share by Application (2019-2030)
5.3 Global Intermediate Bulk Container (IBC) for Pharmaceutical Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Matcon
6.1.1 Matcon Corporation Information
6.1.2 Matcon Description and Business Overview
6.1.3 Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Matcon Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.1.5 Matcon Recent Developments/Updates
6.2 KIT Co,ltd
6.2.1 KIT Co,ltd Corporation Information
6.2.2 KIT Co,ltd Description and Business Overview
6.2.3 KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.2.4 KIT Co,ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.2.5 KIT Co,ltd Recent Developments/Updates
6.3 THIELMANN
6.3.1 THIELMANN Corporation Information
6.3.2 THIELMANN Description and Business Overview
6.3.3 THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.3.4 THIELMANN Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.3.5 THIELMANN Recent Developments/Updates
6.4 GEA
6.4.1 GEA Corporation Information
6.4.2 GEA Description and Business Overview
6.4.3 GEA Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GEA Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.4.5 GEA Recent Developments/Updates
6.5 Dec Group
6.5.1 Dec Group Corporation Information
6.5.2 Dec Group Description and Business Overview
6.5.3 Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dec Group Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.5.5 Dec Group Recent Developments/Updates
6.6 SCHÄFER Werke GmbH
6.6.1 SCHÄFER Werke GmbH Corporation Information
6.6.2 SCHÄFER Werke GmbH Description and Business Overview
6.6.3 SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SCHÄFER Werke GmbH Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.6.5 SCHÄFER Werke GmbH Recent Developments/Updates
6.7 Premier Tech Ltd.
6.6.1 Premier Tech Ltd. Corporation Information
6.6.2 Premier Tech Ltd. Description and Business Overview
6.6.3 Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Premier Tech Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.7.5 Premier Tech Ltd. Recent Developments/Updates
6.8 Ingredient Batching Systems Ltd
6.8.1 Ingredient Batching Systems Ltd Corporation Information
6.8.2 Ingredient Batching Systems Ltd Description and Business Overview
6.8.3 Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ingredient Batching Systems Ltd Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.8.5 Ingredient Batching Systems Ltd Recent Developments/Updates
6.9 ISL Asia Technologies Pte. Ltd.
6.9.1 ISL Asia Technologies Pte. Ltd. Corporation Information
6.9.2 ISL Asia Technologies Pte. Ltd. Description and Business Overview
6.9.3 ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ISL Asia Technologies Pte. Ltd. Intermediate Bulk Container (IBC) for Pharmaceutical Product Portfolio
6.9.5 ISL Asia Technologies Pte. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Chain Analysis
7.2 Intermediate Bulk Container (IBC) for Pharmaceutical Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intermediate Bulk Container (IBC) for Pharmaceutical Production Mode & Process
7.4 Intermediate Bulk Container (IBC) for Pharmaceutical Sales and Marketing
7.4.1 Intermediate Bulk Container (IBC) for Pharmaceutical Sales Channels
7.4.2 Intermediate Bulk Container (IBC) for Pharmaceutical Distributors
7.5 Intermediate Bulk Container (IBC) for Pharmaceutical Customers
8 Intermediate Bulk Container (IBC) for Pharmaceutical Market Dynamics
8.1 Intermediate Bulk Container (IBC) for Pharmaceutical Industry Trends
8.2 Intermediate Bulk Container (IBC) for Pharmaceutical Market Drivers
8.3 Intermediate Bulk Container (IBC) for Pharmaceutical Market Challenges
8.4 Intermediate Bulk Container (IBC) for Pharmaceutical Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Matcon
KIT Co,ltd
THIELMANN
GEA
Dec Group
SCHÄFER Werke GmbH
Premier Tech Ltd.
Ingredient Batching Systems Ltd
ISL Asia Technologies Pte. Ltd.
*If Applicable.